Otsuka Holdings Co., Ltd.
Otsuka Holdings is a Japanese listed holding company whose group businesses include pharmaceutical discovery, development and commercialization alongside other healthcare activities. Its pharmaceutical operations support research into central nervous system disorders, oncology and selected specialty indications through group companies. The parent is based in Japan and trades on the Tokyo Stock Exchange under securities code 4578. This entry describes the listed group's innovative therapeutic business without treating its wider consumer and nutrition businesses as drug development.
Company at a glance
Corporate information
- Company entity
- Otsuka Holdings Co., Ltd.
- Headquarters / principal office
- Japan
- Founded
- Not verified
- Ownership / capital status
- Publicly tradedPublicly listed
- Official corporate reference
- https://www.otsuka.com/en/
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Listed issuer and R&D focus
TSE: 4578
small molecules · biologics · pharmaceutical innovation
central nervous system · oncology · nephrology
Last independently verified:
Disease tags match recorded text mentions and require program-level verification.
Technology, programs & evidence
Otsuka Holdings is a Japanese listed holding company whose group businesses include pharmaceutical discovery, development and commercialization alongside other healthcare activities. Its pharmaceutical operations support research into central nervous system disorders, oncology and selected specialty indications through group companies. The parent is based in Japan and trades on the Tokyo Stock Exchange under securities code 4578. This entry describes the listed group's innovative therapeutic business without treating its wider consumer and nutrition businesses as drug development.
Business, technology & evidence
- SecuritiesTSE: 4578
Individual program detail is not recorded. Consult the original sources below.
Related news & literature
Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.
Showing 0 / 0 related items
No cataloged update explicitly mentions this company.
Same-field reading (not company-specific)
Research this company together
Discussions are for signed-in members. Personal notes remain separate from company research.
Sign in to joinSources & open questions
- Official issuer and R&D disclosure · Otsuka Holdings Co., Ltd. ↗Otsuka Holdings Co., Ltd. ·
Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.